Systemic Inflammatory Response Syndrome (SIRS) Completed Phase 2 Trials for Tocilizumab (DB06273)

Also known as: Septic Syndrome / Systemic Inflammatory Response Syndrome / SIRS / Sepsis syndrome / Systemic inflammatory response syndrome (disorder) / Sepsis syndrome (disorder) / Systemic inflammatory response syndrome (SIRS) of non-infectious origin without acute organ dysfunction / SIRS - System inflammatory response syndrome / Abacteraemic sepsis / Culture-negative sepsis / Abacteremic sepsis

IndicationStatusPhase
DBCOND0053489 (Systemic Inflammatory Response Syndrome (SIRS))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03863015
IL-6 Inhibition for Modulating Inflammation After Cardiac ArrestTreatment